Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SerpinPC in Hemophilia B with Inhibitors (PRESent-3)
NCT05789537Phase 2Terminated
- Sponsor
- ApcinteX Ltd.
- Start
- Jul 2023
- Primary completion
- Nov 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 11
01
Overview
A Phase 2 trial of serpinpc in hemophilia B (HB), sponsored by ApcinteX Ltd.. Started Jul 2023; status: terminated.
02
Drugs
serpinpc
03
Conditions
hemophilia B (HB)
Beyond the preview
Go deeper on NCT05789537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05789537.